Home / Resources / Early Clinical resources

早期临床

精选资源

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

博客

Upcoming early clinical webinars

网络研讨会

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

2026 年 8 月 20 日 – 10:00 - 11:00am ET

网络研讨会

Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech]

2026 年 8 月 20 日 – 3:00 pm – 4:00 pm, Korea time

网络研讨会

Explore Smarter, Faster PK/PD with Phoenix

2026 年 8 月 25 日 – 10-11 AM ET/CET/JST

Latest early clinical blogs

All Early clinical - Blog

Blog

2024 年 Pinnacle 21 Enterprise 用户会议上聚焦临床研究软件

在以下活动中与我们的专家会面

现场活动

Phoenix Pharmacometrics Day – Korea

2026 年 9 月 1 日

现场活动

Phoenix Roadshow 2026 – Tokyo

2026 年 9 月 3 日

会议

Arena Clinical Data Management 2026

2026 年 9 月 9 - 10 日

All early clinical resources

Your Molecule Got More Complex. Did Your FIH Dose Strategy?

Certara Services, Drug Development, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Transforming drug interaction evaluation workflows with DIDB

Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Webinar

A model-informed approach to radioligand therapy dosing under Project Optimus

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Blog

Exploratory data analysis of a drug-biomarker-efficacy PD model

Certara University, Modeling and Simulation - PK/PD, Webinar

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Certara Services, Drug Development, Webinar

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Clinical Pharmacology, Modeling and Simulation - PK/PD, Pharmacometrics, Blog

Go beyond basic validation: Achieve submission-ready datasets with Pinnacle 21 Enterprise

CDISC, Certara Products - Pinnacle 21, Fact Sheet

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

AI & Machine Learning, Certara Products - Phoenix, Modeling and Simulation - PK/PD, Webinar

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Certara Services, Clinical Pharmacology, Drug Development, Infectious Disease, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PK/PD, Publication

Important drug development questions that model-based meta-analysis answers

Certara Services, Clinical Pharmacology, Drug Development Support, Model Informed Drug Development, Modeling and Simulation - MBMA, Blog

Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech]

Certara Products - Pinnacle 21, Certara Products - SEND Explorer, Data Standards, Webinar

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

Biologics, Certara Products - Certara IQ, Modeling and Simulation, Modeling and Simulation - QSP, Publication

1
2
3
……
71
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

早期临床

最新资源

A model-informed approach to radioligand therapy dosing under Project Optimus

Managing drug-drug interaction (DDI) risk for patients in clinical trials

A Quantitative Systems Pharmacology (QSP) Model for Preclinical to Clinical Translation of ADC Efficacy and Thrombocytopenia

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

精选资源

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Upcoming early clinical webinars

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech]

Explore Smarter, Faster PK/PD with Phoenix

Latest early clinical blogs

美国 FDA MIDD 配对试点计划如何帮助赞助商

揭秘临床 DDI 研究：精准测量代谢产物

为何 FDA 批准 omaveloxolone 用于治疗弗里德赖希共济失调症意义重大

细胞疗法开发的主要考虑因素

降低药物开发风险：早期开发中的关键化学、制造和控制（CMC）及基于生理的药代动力学（PBPK）方法

2024 年 Pinnacle 21 Enterprise 用户会议上聚焦临床研究软件

在以下活动中与我们的专家会面

Phoenix Pharmacometrics Day – Korea

Phoenix Roadshow 2026 – Tokyo

Arena Clinical Data Management 2026

All early clinical resources

Your Molecule Got More Complex. Did Your FIH Dose Strategy?

Transforming drug interaction evaluation workflows with DIDB

A model-informed approach to radioligand therapy dosing under Project Optimus

Exploratory data analysis of a drug-biomarker-efficacy PD model

Investor panel: What it takes to build a fundable biotech – with Life Science Nation

RsNLME meets MCP: the pharmacometric AI assistant scientists have been asking for

Go beyond basic validation: Achieve submission-ready datasets with Pinnacle 21 Enterprise

From Sentence to Simulation: Bringing AI Assistance to Pharmacometrics Modeling

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Important drug development questions that model-based meta-analysis answers

Unlock the Power of SEND Data: From FDA Compliance to Global Regulatory Readiness for Preclinical Data [Korean Webinar with Biotoxtech]

Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data

订阅时事通讯

快捷链接

解决方案

联系我们